DRKS00016752RecruitingNot Applicable
''Diagnostic value of optical spectral transmission in patients with inflammatory rheumatic diseases'' - OST
ACURA Rheumatology Center0 sites500 target enrollmentStarted: February 21, 2019Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 500
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 Years to 90 Years (—)
- Sex
- All
Inclusion Criteria
- •Inflammatory Joint disease
Exclusion Criteria
- •Deformities of the hands, joint implants, Pregnancy, photosensitivity
Investigators
Similar Trials
Recruiting
Not Applicable
Optisch spectraal transmissie voor therapie monitoring en correlatie met arteriële vaatstijfheid bij patiënten met reumatoïde artritis die gaan starten met TNF remmende therapieRheumatoid arthritis,Cardiovascular diseaseNL-OMON20387Reade Center for Rehabilitation and Rheumatology40
Completed
Not Applicable
Optical spectral transmission imaging for treatment monitoring and correlation with arterial stiffness in patients with rheumatoid artritis starting with TNF inhibiting therapyrheumatoid arthritisNL-OMON48787Reade62
Recruiting
Not Applicable
Value of usefulness of diffuse optical spectroscopic imaging for monitoring efficacy of aingle agent bevacizumab followed by Paclitaxel in breast cancer patientsStage3/4 breast cancer patientsJPRN-UMIN000015837International Medical Center, Saitama Medical University30
Completed
Not Applicable
INFINITY ISRIn-stent restenosis: ISRJPRN-UMIN000052799Tokyo Bay Urayasu Ichikawa Medical Center116
Completed
Not Applicable
OCT in Amblyopic ChildreCTRI/2018/04/012942Giridhar Eye Institute50